These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 2664924)

  • 1. [Role of insulin and counter-regulatory hormones in the metabolic changes caused by insulin deprivation in diabetic patients].
    Castillo MJ; Scheen AJ; Gualda P; Lefebvre PJ
    Rev Esp Fisiol; 1989 Mar; 45(1):53-9. PubMed ID: 2664924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics.
    Giugliano D; Luyckx AS; Lefebvre PJ
    Diabete Metab; 1980 Mar; 6(1):39-46. PubMed ID: 6989660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolic response to insulin deprivation in idiopathic brittle diabetes.
    Husband DJ; Pernet A; Gill GV; Hanning I; Alberti KG
    Diabetes Res; 1986 May; 3(4):193-8. PubMed ID: 3527516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
    Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH
    J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of beta-adrenergic role for catecholamines in the development of hyperglycemia and ketonaemia following acute insulin withdrawal in type I diabetic patients.
    Beylot M; Sautot G; Dechaud H; Cohen R; Riou JP; Serusclat P; Mornex R
    Diabete Metab; 1985 Apr; 11(2):111-7. PubMed ID: 2989015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon, insulin, cortisol, and growth hormone levels following major surgery: their relationship to glucose and free fatty acid elevations.
    Göschke H; Bär E; Girard J; Leutenegger A; Niederer W; Oberholzer M; Wolff G
    Horm Metab Res; 1978 Nov; 10(6):465-70. PubMed ID: 744565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulsatile rather than continuous glucagon infusion leads to greater metabolic derangements in insulin-dependent diabetic subjects.
    Paolisso G; Sgambato S; Giunta R; Varricchio M; D'Onofrio F
    Diabete Metab; 1990; 16(1):42-7. PubMed ID: 2332096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of insulin antibodies on metabolic deterioration after interruption of continuous subcutaneous insulin infusion.
    Montaña E; Fernández-Castañer M; Rosel P; Gómez JM; Vinzia C; Soler J
    Diabete Metab; 1990; 16(3):220-5. PubMed ID: 2210017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inappropriate counter-regulatory hormone levels in insulin treated diabetes.
    Danowski TS; Fisher ER; Kozak W; Bahl VK; Stephan T; Nolan S; Ahmad U
    Behav Neuropsychiatry; 1976 Apr-1977 Mar; 8(1-12):6-15. PubMed ID: 1052263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon.
    Gerich JE; Lorenzi M; Bier DM; Schneider V; Tsalikian E; Karam JH; Forsham PH
    N Engl J Med; 1975 May; 292(19):985-9. PubMed ID: 804137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inappropriate counter-regulatory hormone levels in insulin treated diabetes.
    Danowski TS; Fisher ER; Kozak W; Bahl VK; Stephan T; Nolan S; Ahmad U
    PDM; 1976; 7(9-12)8(1-8):7-16. PubMed ID: 1052833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lack of benefit from the intermittent administration of insulin in treatment using subcutaneous perfusion pump in type 1 diabetes].
    Lilet H; Krzentowski G; Bodson A; Scheen AJ; Lefebvre PJ
    Diabete Metab; 1991; 17(3):363-72. PubMed ID: 1884881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscular exercise in type I-diabetics. II. Hormonal and metabolic responses to moderate exercise.
    Zander E; Schulz B; Chlup R; Woltansky P; Lubs D
    Exp Clin Endocrinol; 1985 Feb; 85(1):95-104. PubMed ID: 3886416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic effects of low-dose incremental insulin infusion in diabetic man.
    Hale PJ; Black E; Nattrass M
    Horm Metab Res; 1986 Feb; 18(2):129-33. PubMed ID: 3516823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a two hour proinsulin infusion on the glucose lowering potency of a following insulin injection.
    Hübinger A; Randerath W; Tosetti P; Schlüter KJ; Gries FA
    Horm Metab Res Suppl; 1988; 18():34-7. PubMed ID: 3056809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic effects of adrenaline and noradrenaline in man: studies with somatostatin.
    Pernet A; Walker M; Gill GV; Orskov H; Alberti KG; Johnston DG
    Diabete Metab; 1984 May; 10(2):98-105. PubMed ID: 6146542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolic risks of salbutamol in diabetic patients. A study using somatostatin (author's transl)].
    Schlienger JL; Compagnie MJ; Dellenbach P; Stephan F
    Nouv Presse Med; 1980 Sep; 9(32):2247-51. PubMed ID: 6106923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evolution of hormonal parameters (glucagon, cortisol, growth hormone) and energetic parameters (glucose, fatty acids, free glycerol) in 10 severe cases of diabetic acido-ketosis under treatment].
    Assan R; Hautecouverture G; Guillemant S; Dauchy F; Protin P; Derot M
    Pathol Biol (Paris); 1969 Dec; 17(23):1095-105. PubMed ID: 4985195
    [No Abstract]   [Full Text] [Related]  

  • 19. Hormonal and metabolic response to physical exercise in hyperinsulinemic and non-hyperinsulinemic type 2 diabetics.
    Hübinger A; Franzen A; Gries FA
    Diabetes Res; 1987 Feb; 4(2):57-61. PubMed ID: 3555953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous intraperitoneal insulin infusion partly restores the glucagon response to hypoglycaemia in type 1 diabetic patients.
    Oskarsson PR; Lins PE; Backman L; Adamson UC
    Diabetes Metab; 2000 Apr; 26(2):118-24. PubMed ID: 10804326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.